Crypto News

Aug 25, 2026

Moderna (MRNA) Stock Soars 14% on Personalized Cancer Vaccine Success: Is It Time to Buy?

Stocks

Moderna (MRNA) stock jumps 14% as its personalized mRNA cancer vaccine meets Phase 3 trial goals. Analysts boost price targets, but is the rally sustainable?

The post Moderna (MRNA) Stock Soars 14% on Personalized Cancer Vaccine Success: Is It Time to Buy? appeared first on Blockonomi.

Source: Blockonomi →

Related News

Trending Category

$BMNR200-day moving average24/7 trading4-Year Cycle50-Week Moving AverageAB 2409AGIXAIAI AgentsAI Data CentersAI IPO marketAI InfrastructureAI StocksAI automationAI backlashAI capital rotationAI spendingAMD StockAMLAML compliance

Latest News